Category : Search result: pharmaceutical supply


Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

U.S. Critical Minerals Crisis: Copper, Uranium Shortages Loom

Exclusive analysis reveals America's alarming dependence on foreign nations for essential minerals including copper, uranium, and potash. Discover how this vulnerability impacts everything from energy security to food production and what strategic moves a

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Herschel x Heinz: Vancouver Brand's Ketchup Collab

Vancouver's beloved Herschel Supply Co. teams up with Heinz in a surprising fashion collaboration featuring ketchup-inspired accessories. Discover the limited-edition collection blending street style with iconic condiment branding.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Alberta Pharmacy Vaccine Rollout Faces Bottlenecks

Albertans seeking COVID-19 vaccinations are encountering significant wait times at pharmacies across the province as limited vaccine supply struggles to meet overwhelming public demand.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

DP World Ships 400 Tons of Peruvian Blueberries to U.S.

Global trade leader DP World successfully transports 400 tons of fresh Peruvian blueberries to American consumers, showcasing efficient cold chain logistics and expanding North American fruit availability.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Windsor Port Expansion Could Generate $26.4M Boost

A groundbreaking economic study shows Windsor's strategic port expansion could unlock massive economic benefits and create new international trade opportunities for Canadian businesses.

Page 4 of 4